Holen Sie sich die Stockscreener-App
77.15
1.39%
-1.09
Handel nachbörslich:
77.16
0.010
+0.01%
Schlusskurs vom Vortag:
$78.24
Offen:
$77.98
24-Stunden-Volumen:
1.31M
Relative Volume:
0.78
Marktkapitalisierung:
$13.36B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
9.4498
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
+4.27%
1M Leistung:
+2.94%
6M Leistung:
-2.64%
1J Leistung:
+1.73%
1-Tages-Spanne:
$76.65
$77.98
1-Wochen-Bereich:
$74.26
$80.60
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
77.15 | 13.77B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
397.68 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
151.33 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.44 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.10 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
194.88 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
solventum-logo-horz-clr-rev-rgb - Dentistry UK
Solventum (SOLV) Is Up 6.4% After Russell 2500 Value Inclusion Shifted Its Healthcare Role - simplywall.st
Solventum stock: Is SOLV underperforming the healthcare sector? - MSN
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Solventum Corporation(NYSE: SOLV) added to Russell 2500 Index - marketscreener.com
Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
3M updates health spinoff tax details, shares stay on investor radar - Ad-hoc-news.de
Price to sales forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Solventum Corporation Actuals & Estimates (NYSE:SOLV) - TradingView
Enterprise value to revenue forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
SOLV Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum (SOLV) Short Interest & Short Float | Updated Jun 2026 $SOLV - MarketBeat
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Stock Sinks as Investors Question Its Health - TipRanks
Why Is (NYSE:SOLV) Advancing Healthcare Growth in the S&P 500? - Kalkine Media
What Solventum (SOLV) Results Mean As Growth Plans Support Its Valuation - simplywall.st
Solventum (SOLV) Holds Steady Near Support as Resistance LoomsGrowth Stock Picks - Město Břeclav
Solventum Corp (SOLV) Institutional Confidence - TradingKey
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum Data Breach Lawsuit Investigation - Claim Depot
Solventum Corporation (SOLV) Stock Report: Insights into a Healthcare Giant with 8.91% Potential Upside - DirectorsTalk Interviews
Solventum Stock: Is SOLV Underperforming the Healthcare Sector? - Barchart.com
Should Solventum’s (SOLV) Recent US$1 Billion Slide and Weaker Metrics Require Action From Investors? - simplywall.st
Solventum Corp (SOLV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Solventum Corp (SOLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Solventum Corp (SOLV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Solventum Corp (SOLV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Solventum Corp (SOLV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Solventum Corp (SOLV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum Corp (SOLV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Solventum Stock Plummets -7.2% With 5-Day Losing Streak - Trefis
Solventum Stock Slides 7.2% With A 5-Day Losing Spree - Trefis
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum (SOLV) Edges Lower as Price Consolidates Between Key LevelsBull Pennant - newsline.com
Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains - Yahoo Finance
Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate - Yahoo Finance
Solventum Data Breach Affects Patient Info, Lawsuit Possible - ClassAction.org
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
Is Solventum Corporation (SOLV) A Good Stock To Buy Now? - Insider Monkey
Daily Brief Health Care: Laurus Labs, Ascendis Pharma, GSK , Incyte Corp, Insmed Inc, Johnson & Johnson, Kardigan, LogicMark, Parabilis Medicines, Solventum and more - Smartkarma
The future of clear aligners: how Clarity Aligners from Solventum can improve treatment precision - Digital Journal
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
3M Company stock (US88579Y1010): Spin-off hangover and legal risks keep investors on edge - AD HOC NEWS
3M Company stock (US88579Y1010): Board shake-up and post-spin future after Solventum deal - AD HOC NEWS
Why Solventum Stock Is Sinking Despite Strong Earnings - TipRanks
Solventum trends for 2026: AI coding, tariffs, and margins - MSN
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solventum Corp-Aktie (SOLV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McMillan Wayde D. | Chief Financial Officer |
May 13 '26 |
Option Exercise |
0.00 |
9,503 |
0 |
53,041 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '26 |
Option Exercise |
0.00 |
3,960 |
0 |
22,130 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '26 |
Option Exercise |
0.00 |
2,376 |
0 |
7,632 |
| Kirberger Marcela A. | Chief Legal Affairs Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,488 |
0 |
15,492 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '26 |
Option Exercise |
0.00 |
34,315 |
0 |
158,225 |
| Landucci Amy | Chief Information Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,422 |
0 |
41,905 |
| Wendell Amy McBride | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
10,422 |
| WEILAND JOHN H | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
| Mily Elizabeth | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
9,009 |
| Wilson Darryl L. | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
0.45%
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):